We are live on ! Find out more
REPL icon

Replimune Group

61 hedge funds and large institutions have $316M invested in Replimune Group in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

750% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 2

222% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 9

100% more funds holding in top 10

Funds holding in top 10: 24 (+2)

22% more capital invested

Capital invested by funds: $258M → $316M (+$57.8M)

20% more funds holding

Funds holding: 5161 (+10)

3.05% more ownership

Funds ownership: 58.64%61.7% (+3.1%)

Holders
61
Holders Change
+10
Holders Change %
+19.61%
% of All Funds
1.2%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.08%
New
17
Increased
29
Reduced
9
Closed
2
Calls
Puts
Net Calls
Net Calls Change

REPL Hedge Fund Activity: Q4 2019 in Review

61 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Replimune Group (REPL) for Q4 2019, worth a combined $316M — up 22% from $258M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new REPL positions and 2 closed out — a net gain of 15 holders — while 29 added to existing stakes and 9 trimmed.

The largest buyer was BVF Inc, adding an estimated $8.06M. The largest seller was Foresite Capital Management III, cutting an estimated $3.69M.

  • 61 institutional investors held Replimune Group (REPL) as of Q4 2019, up from 51 in Q3 2019.
  • Funds reported $316M of Replimune Group stock for Q4 2019, up 22% quarter-over-quarter.
  • 17 funds opened new Replimune Group positions in Q4 2019 and 2 closed out, a net change of +15 holders.
  • The largest Replimune Group buyer in Q4 2019 was BVF Inc, an estimated $8.06M added.
  • The largest Replimune Group seller in Q4 2019 was Foresite Capital Management III, an estimated $3.69M sold.

Based on aggregated 13F filings for Q4 2019.